Item 2.
The Company’s total net sales worldwide in the 13 weeks ended November 26, 2017 were lower than such sales in the 13 weeks ended August 27, 2017 primarily as a result of lower sales of the Company’s printed circuit materials in the 13 weeks ended November 26, 2017.
The Company’s total net sales of its printed circuit materials products were $15.9 million and $53.1 million, respectively, in the 13 weeks and 39 weeks ended November 26, 2017, or 61% and 64%, respectively, of the Company’s total net sales worldwide in such periods, compared to $19.0 million and $63.0 million, respectively, in the 13 weeks and 39 weeks ended November 27, 2016, or 72% of the Company’s total net sales worldwide in each such periods.
Selling, general and administrative expenses increased by $193,000 during the 13 weeks ended November 26, 2017, or by 4%, and decreased by $1,084,000 during the 39 weeks ended November 26, 2017, or by 7%, compared to last fiscal year's comparable periods, and these expenses, measured as percentages of sales, was 18.4% and 16.7%, respectively, in the 13 weeks and 39 weeks ended November 26, 2017 compared to 17.4% and 17.3%, respectively, in the 13 weeks and 39 weeks ended November 27, 2016.
The increase in such expenses during the 13 weeks ended November 26, 2017 were primarily the result of advisory fees of $190,000.
The decrease in such expenses during the 39 weeks ended November 26, 2017 was primarily the result of lower payroll, profit sharing and stock option expenses.
During the 39 weeks ended November 26, 2017, selling, general and administrative expenses included the advisory fees mentioned above and a one-time litigation expense of $375,000.
Selling, general and administrative expenses included stock option expenses of $234,000 and $709,000, respectively, for the 13 weeks and 39 weeks ended November 26, 2017, compared to stock option expenses of $264,000 and $968,000, respectively, for the 13 weeks and 39 weeks ended November 27, 2016.
Other interest rate options are were available to the Company under the agreement.
Interest income was $734,000 and $2.2 million, respectively, for the 13 weeks and 39 weeks ended November 26, 2017 compared to $430,000 and $1.2 million, respectively, for last fiscal year's comparable periods.
In the 13 weeks and 39 weeks ended November 26, 2017, basic and diluted earnings per share were $0.04 and $0.13, respectively, including, in both such periods, the restructuring charges, litigation expense and advisory fees described above.
The net impact of the restructuring charges, litigation and advisory fees described above reduced basic and diluted earnings per share by $0.02 and $0.16, respectively, in the 13 weeks and 39 weeks ended November 26, 2017.None.
Item 5.Item 1.
Legal Proceedings.
None.
None.